Cargando…
Effect of Intravenous Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation (EFFECT-KTx): rationale and study protocol for a double-blind, randomised, placebo-controlled trial
INTRODUCTION: Iron deficiency (ID) is common and has been associated with an excess mortality risk in kidney transplant recipients (KTRs). In patients with chronic heart failure and ID, intravenous iron improves exercise capacity and quality of life. Whether these beneficial effects also occur in KT...
Autores principales: | Vinke, Joanna SJ, Eisenga, Michele F, Sanders, Jan-Stephan F, Berger, Stefan P, Spikman, Jacoba M, Abdulahad, Wayel H, Bakker, Stephan JL, Gaillard, Carlo A J M, van Zuilen, Arjan D, van der Meer, P, de Borst, Martin H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040026/ https://www.ncbi.nlm.nih.gov/pubmed/36948568 http://dx.doi.org/10.1136/bmjopen-2022-065423 |
Ejemplares similares
-
Ferric carboxymaltose and SARS-CoV-2 vaccination-induced immunogenicity in kidney transplant recipients with iron deficiency: The COVAC-EFFECT randomized controlled trial
por: Vinke, Joanna Sophia J., et al.
Publicado: (2023) -
Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
por: Hofman, Jesse M. G., et al.
Publicado: (2018) -
Intravenous ferric carboxymaltose for anaemia in pregnancy
por: Froessler, Bernd, et al.
Publicado: (2014) -
Hypophosphatemia in children treated with ferric carboxymaltose
por: Posod, Anna, et al.
Publicado: (2020) -
Diagnostic yield of massively parallel sequencing in patients with chronic kidney disease of unknown etiology: rationale and design of a national prospective cohort study
por: de Haan, Amber, et al.
Publicado: (2022)